Ildong Pharmaceutical Co., Ltd. (KRX: 249420)

Ildong Pharmaceutical Revenue

Ildong Pharmaceutical had revenue of 155.95B KRW in the quarter ending September 30, 2024, with 4.29% growth. This brings the company's revenue in the last twelve months to 610.28B, up 1.44% year-over-year. In the year 2023, Ildong Pharmaceutical had annual revenue of 600.76B, down -5.80%.

• Revenue (ttm): 610.28B
• Revenue Growth: +1.44%
• P/S Ratio: 0.50
• Revenue / Employee: 590.79M
• Employees: 1,033
• Market Cap: 305.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	600.76B	-36.96B	-5.80%
Dec 31, 2022	637.71B	77.58B	13.85%
Dec 31, 2021	560.13B	-1.71B	-0.30%
Dec 31, 2020	561.85B	44.38B	8.58%
Dec 31, 2019	517.47B	13.56B	2.69%